Sharon Klahre | Senior Director-Investor Relations |
Ankit Mahadevia | Co-Founder, President and Chief Executive Officer |
David Melnick | Chief Medical Officer |
Cristina Larkin | Chief Operating Officer |
Steve DiPalma | Interim Chief Financial Officer |
Ritu Baral | Cowen |
Louise Chen | Cantor |
Stephen Willey | Stifel |
Ram Selvaraju | H.C. Wainwright |
Chi Fong | Bank of America |
Greetings, and welcome to the Spero Therapeutics Second Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sharon Klahre. Thank you.
You may begin.